Wise covers the Healthcare sector, focusing on stocks such as Artivion, Medtronic, and Zimmer Biomet Holdings ... The company develops, manufactures and sells medical supplies, devices, laboratory ...

The rapidly growing aging population is driving expansion in healthcare, with rising demand for treatments and chronic disease management. Companies like AbbVie (ABBV), Medtronic (MDT), and Centene ...

The Neuroscience Portfolio segment offers medical devices and implants ... Latest Health Care Equipment & Supplies and Abbott Laboratories, Medtronic plc Stock News As of November 7, 2024, Abbott ...

Shanghai's economy has maintained strong resilience and vitality, holding significance for long-term strategic investments by ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

Q3 2024 Earnings Call Transcript November 7, 2024 ClearPoint Neuro, Inc. misses on earnings expectations. Reported EPS is $-0.18 EPS, expectations were $-0.17. Operator: Greetings, and welcome to the ...

Good morning and thank you for joining the Integra LifeSciences Third Quarter 2024 Earnings Conference Call. With me on the ...

Medtronic and Recor Medical may have some fresh resolutions for the new year after the Centers for Medicare & Medicaid Services (CMS) recently approved reimbursements for the two companies ...

About a year ago, renal denervation procedures won a huge victory after finally being greenlit by FDA. Now two of the frontrunners in the space have received reimbursement.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

[Illustration courtesy of Medtronic] Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation (RDN) technologies. Going into ...